<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02907463</url>
  </required_header>
  <id_info>
    <org_study_id>2015-05</org_study_id>
    <nct_id>NCT02907463</nct_id>
  </id_info>
  <brief_title>EDWARDS INTUITY Elite Valve System</brief_title>
  <acronym>MISSION</acronym>
  <official_title>Assessing Clinical Outcomes Using the EDWARDS INTUITY Elite Valve System in Isolated AVR Using Minimally InvaSive Surgery In a EurOpean Multi-ceNter, Active, Post-market Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this active, observational, open-label, non-randomized, post-market
      surveillance study is to confirm that EDWARDS INTUITY Elite reduces cross clamp time (XCT) in
      MIS setting when compared to published data with a conventional valve within the MIS setting.
      The published dataset will used as a control group. Then to describe short term (30 days) and
      long term (6 months) clinical safety, to assess and compare hemodynamic data with EDWARDS
      INTUITY Elite to a conventional valve at discharge and at 6 months post AVR, to assess
      Quality of Life at baseline, and at 6 months post AVR to assess NYHA functional class at
      baseline, discharge, 1 month and at 6 months post AVR to assess Fitness for hospital
      discharge.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aortic valve replacement with mechanical or biological heart valves is the treatment of
      choice for aortic valve stenosis. Over the past several years, life expectancy has increased
      in industrial nations, but this has been accompanied by a rising rate of elderly patients
      with multiple illnesses.

      Aortic stenosis remains the most common cause of adult valvular heart disease, the prevalence
      increasing with age. Average survival of patients treated conservatively has historically
      been reported as 2â€”5 years from the onset of symptoms. More recent studies have confirmed the
      dismal prognosis of severe aortic stenosis. Advanced age, reduced left-ventricular ejection
      fraction, congestive heart failure and renal insufficiency appear to be independent
      predictors of reduced survival. Asymptomatic patients with very severe aortic stenosis also
      share a poor prognosis with a high event rate and a risk of rapid functional deterioration.
      Early surgery offers a therapeutic option to improve clinical outcomes via decreasing cardiac
      mortality and improving symptoms.

      Bioprostheses offer several advantages over mechanical bioprostheses, the most important
      being freedom from anticoagulation with a low rate of thromboembolic accidents.

      In response to clinical need and in support of advances in minimally invasive surgical
      approaches to conventional AVR, Edwards Lifesciences developed the EDWARDS INTUITY Elite
      Valve System to achieve clinical benefits by reducing cardiopulmonary bypass and cross clamp
      times, while facilitating a less invasive approach to aortic valve replacement.

      The system includes the EDWARDS INTUITY Elite Valve System, Model 8300AB and the EDWARDS
      INTUITY Elite Delivery System, Model 8300DB; the valve is based on prior heart valve designs
      which have a long history of safety and effectiveness and have incorporated additional
      features designed to improve patient outcomes and safety.

      With only 3 guiding sutures and secure balloon expandable frame, the EDWARDS INTUITY Elite
      Valve system is well suited for smaller incisions and tight access, with an emphasis on
      procedural efficiency within existing operating suite of the surgeon.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Subject's Average Time Spent on Cardiopulmonary Cross Clamp</measure>
    <time_frame>At time of surgery; an average of 1 hour</time_frame>
    <description>Cardiopulmonary cross clamp time is the amount of time that the patient's aorta (blood vessel) is clamped by a surgical instrument used in cardiac surgery. This allows the normal blood flow to be sent to an artificial heart and lung machine to keep it at a constant temperature and oxygen level.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject's Average Time Spent on Cardiopulmonary Bypass.</measure>
    <time_frame>At time of surgery; an average of 1.5 hours</time_frame>
    <description>Cardiopulmonary bypass time is the amount of time that the patient's blood circulates through an artificial heart and lung machine during cardiac surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device Technical Success Rate</measure>
    <time_frame>At time of surgery</time_frame>
    <description>The successful delivery and deployment of the EDWARDS INTUITY Elite valve and delivery system, and the subject leaving the operating room with valve in place.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First Attempt Success Rate</measure>
    <time_frame>At time of surgery</time_frame>
    <description>The successful delivery and deployment of the valve and delivery system during the first attempt, and subject leaving the operating room with EDWARDS INTUITY Elite valve in place.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Success</measure>
    <time_frame>Day of procedure and events occurring within 10 days of procedure</time_frame>
    <description>Procedural success is defined as device technical success followed by the absence of adverse events requiring device reoperation, requiring implantation of permanent pacemaker (with baseline sinus rhythm and no other conduction issues), or subject death, within discharge or 10 days post index procedure whichever comes first.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject's Average Health Care Utilization</measure>
    <time_frame>Day of surgical procedure through discharge from the hospital, an average of 3 days and 10 days respectively.</time_frame>
    <description>The average amount of time the subjects spent in the intensive care unit and the average total length of hospital stay after their heart valve replacement procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject's Average Mean Gradient Measurements Over Time.</measure>
    <time_frame>Baseline, Discharge and 6 months</time_frame>
    <description>Mean gradient is the average flow of blood through the aortic valve measured in millimeters of mercury. Gradients are evaluated by echocardiography over time. Mean gradient values depend on the size and type of valve.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject's Average Peak Gradients Measurements Over Time.</measure>
    <time_frame>Baseline, Discharge and 6 months</time_frame>
    <description>Peak gradient is the maximum value measured of flow of blood through the aortic valve as measured in millimeters of mercury. Gradients are evaluated by echocardiography over time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject's Average Effective Orifice Area (EOA) Measurements Over Time</measure>
    <time_frame>Baseline, Discharge and 6 months</time_frame>
    <description>Effective orifice area represents the cross-sectional area of the blood flow downstream of the aortic valve. Effective orifice area is evaluated by echocardiography over time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject's Average Effective Orifice Area Index (EOAI) Measurement Over Time.</measure>
    <time_frame>Discharge and 6 months</time_frame>
    <description>Effective orifice area index represents the minimal cross-sectional area of the blood flow downstream of the aortic valve divided by the person's body surface area. Effective orifice area index is evaluated by echocardiography over time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject's Average Performance Index Measurements Over Time.</measure>
    <time_frame>Baseline, Discharge and 6 months</time_frame>
    <description>Performance index is defined as the subject's effective orifice area (the cross-sectional area of the blood flow downstream of the aortic valve) divided by the subject's pre-implant orifice area. Effective orifice area is evaluated by echocardiography over time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject's Average Cardiac Output Over Time</measure>
    <time_frame>Baseline, Discharge and 6 months</time_frame>
    <description>The amount of blood the heart pumps through the circulatory system in a minute.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject's Average Cardiac Index</measure>
    <time_frame>Discharge and 6 months</time_frame>
    <description>A measure of cardiac output per square meter of body surface area</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject's Amount of Paravalvular Leak Over Time.</measure>
    <time_frame>Discharge and 6 months</time_frame>
    <description>Paravalvular leak refers to blood flowing through a channel between the implanted artificial valve and the cardiac tissue as a result of inappropriate sealing. Paravalvular leak is evaluated by echocardiography over time. It is assessed on a scale from minimum of 0 to maximum of 4, where 0 = no leak, 1 = a trace leak, 2 = a mild leak, 3 = a moderate leak, and 4 = a severe leak. Higher numbers on the scale show a worsening outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject's Amount of Aortic Valvular Regurgitation Over Time.</measure>
    <time_frame>Discharge and 6 Months</time_frame>
    <description>Aortic valvular regurgitation occurs when the aortic valve in the heart does not close tightly allowing some of the blood that was pumped out of the heart to leak back into it. Aortic valvular regurgitation is evaluated by echocardiography over time. It is assessed on a scale from minimum of 0 to maximum of 4, where 0 = no leak, 1 = a trace leak, 2 = a mild leak, 3 = a moderate leak, and 4 = a severe leak. Higher numbers on the scale show a worsening outcome.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Subject's Average SF-36 Physical Health Summary</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>The Medical Outcomes Study Short-Form 36 - Physical Health Summary The SF-36 questionnaire scale ranges from 100, which reflects the best health status to 0, which reflects the worse health status.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Average SF-36 Mental Health Summary</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>The Medical Outcomes Study Short-Form 36 - Mental Health Summary The SF-36 questionnaire scale ranges from 100, which reflects the best health status to 0, which reflects the worse health status.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's New York Heart Association (NYHA) Functional Class Compared to Baseline</measure>
    <time_frame>6 months compared to baseline</time_frame>
    <description>The New York Heart Association (NYHA) functional classification system relates symptoms to everyday activities and the patient's quality of life. Class I. Patients with cardiac disease but without resulting limitation of physical activity.
Class II. Patients with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest.
Class III. Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest.
Class IV. Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort.
Symptoms of heart failure or the anginal syndrome may be present even at rest.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Average Score on the EQ-5D - Quality of Life Questionnaire Over Time</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>The EuroQol-5 Dimension (EQ-5D) is a standardized questionnaire that asks subjects to rate themselves (no problems, some problems, extreme problems) on mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The scale is indexed and ranges from a minimum of 0.275 and a maximum of 1.000. A lower number indicates the participants experiences more problems and a higher number indicates the participants experiences fewer problems.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Average Fitness for Hospital Discharge</measure>
    <time_frame>Day of surgical procedure through discharge from the hospital; an average of 7 days</time_frame>
    <description>Considered as the day at which the patient was fit for hospital discharge.</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of Early Adverse Events Divided by Number of Subjects (Expressed as a Percentage)</measure>
    <time_frame>Events occurring within 30 days of procedure</time_frame>
    <description>Number of early adverse events occurring within 30 days of procedure divided by the number of enrolled subjects times 100</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of Late Adverse Events Divided by Late Patient Years (Expressed as a Percentage)</measure>
    <time_frame>Events occuring &gt;= 31 days and up through 6 months</time_frame>
    <description>Number of late adverse events divided by the total number of late patient years x 100. Late patient years are calculated from 31 days post-implant to the date of the last contact (follow up or adverse event).</description>
  </other_outcome>
  <enrollment type="Actual">280</enrollment>
  <condition>Aortic Valve Disease</condition>
  <condition>Aortic Stenosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        -  Adult subjects, age18 or older, that have been diagnosed with aortic stenosis or
             stenosis-based insufficiency requiring isolated aortic valve replacement (AVR)

          -  Subjects whose medical records indicate they are a suitable candidate for Minimally
             Invasive Surgery (MIS)

          -  Subjects whose treating physician is the Principle Investigator or a Sub-Investigator
             participating in the study and has been trained on the EDWARDS INTUITY Elite Valve
             System

          -  Subject shall be drawn from the general patient population served by each
             investigational center

          -  Candidates for this study must meet all of the following Inclusion criteria and none
             of the Exclusion criteria or intra-op exclusion criteria
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is 18 years or older

          2. Subject is symptomatic for aortic stenosis (AS) or mixed aortic stenosis and aortic
             insufficiency (AS/AI) disease for which isolated surgical aortic valve replacement
             without concomitant procedures is indicated according to International guidelines.

          3. Surgery starts with and is intended to be completed via a minimal invasive surgical
             approach. MIS is defined as a non-full sternotomy approach such as partial
             hemi-sternotomy, right anterior thoracotomy.

          4. Surgery is intended to be completed with an EDWARDS INTUITY Elite Heart Valve.

          5. Subject has signed and dated the investigation informed consent forms prior to any
             study-specific procedures are performed.

          6. Subject is geographically stable and agrees to attend follow-up assessments as
             specified in the protocol and informed consent.

        Exclusion Criteria:

          1. Subject is diagnosed with pure aortic insufficiency.

          2. Subject requires multiple valve replacement/repair

          3. Subject has Type 0 congenital true bicuspid aortic valve (i.e. absence of raphe and
             commissures are positioned about 180 degrees apart) or unicuspid aortic valve.

          4. Subject has severe ventricular dysfunction defined as LVEF &lt; 25%.

          5. Subject has a history of active endocarditis and/or myocarditis â‰¤ 3 months before the
             intended treatment/scheduled surgery.

          6. Subject has had an acute MI â‰¤ 3 months before the intended treatment.

          7. Subject had a stroke or transient ischemic attack within six months prior to scheduled
             aortic valve replacement surgery.

          8. Subject is oxygen or ventilator dependent.

          9. Subject has life expectancy &lt; 12 months.

         10. Female subject is pregnant or lactating.

         11. Subject with documented leukopenia (WBC &lt; 3.5x 103/Î¼L), anemia (Hb &lt; 10.0 gm/dL or &lt;
             6.2 mmol/L), thrombocytopenia (platelet count &lt; 100x 103/mL), or history of bleeding
             diathesis or coagulopathy.

         12. Subject has renal insufficiency as determined by Serum creatinine

             â‰¥ 200 Î¼mol/L (2.27 mg/dL) at screening or end-stage renal disease requiring chronic
             dialysis.

         13. Subject is currently participating in an investigational drug or device trial for
             which follow-up has not yet been completed.

         14. Minimally Invasive access to the heart is not possible due to anatomical constraints
             or any other pre-existing condition.

         15. Aneurysm of the aortic root and/or ascending aorta

        Intra-operative exclusion criteria:

          1. Subject has Type 0 congenital true bicuspid aortic valve (i.e. absence of raphe and
             commissures are positioned about 180 degrees apart) or unicuspid aortic valve. (A
             non-congenital bicuspid valve without a distorted annulus would not be cause for
             exclusion.)

          2. Subject has calcium on the anterior mitral leaflet which cannot be removed.

          3. Subject has extensive calcification of the aortic root.

          4. Annular deformation which may or may not be caused by too extensive decalcification of
             the aortic annulus.

          5. The position of the coronary ostia relative to the EDWARDS INTUITY Elite Aortic Valve
             could result in obstruction of blood flow.

          6. Minimally Invasive access to the heart is not possible due to anatomical constraints
             or any other condition (including patient switched to a full sternotomy approach).

          7. The device is not available in the correct size for the subject.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher Young, MD FRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Thomas' Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gunther Laufer, Prof. Dr. med</last_name>
    <role>Principal Investigator</role>
    <affiliation>AKH Vienna Dep. of Cardiovascular Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinik fÃ¼r Herzchirurgie Medizinische UniversitÃ¤t Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinisshe Abteiluing FÃ¼r Herz-thoraxchirurgie</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aarhus Universitets Hospital Skejby</name>
      <address>
        <city>Aarhus N</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Bocage Central Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21074</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Cardiologique CHU Bordeaux Haut Leveque</name>
      <address>
        <city>Pessac Cedex</city>
        <zip>33 604</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz- und GefÃ¤ÃŸ-Klinik GmbH Bad Neustadt</name>
      <address>
        <city>Bad Neustadt An Der Saale</city>
        <zip>97616</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum der Ruhr-UniversitÃ¤t Bochum Klinik fÃ¼r Herz- und Thoraxchirurgie</name>
      <address>
        <city>Bochum</city>
        <zip>44789</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Uniklinik KÃ¶ln</name>
      <address>
        <city>Cologne</city>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital WÃ¼rzburg</name>
      <address>
        <city>Wurzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>G. Pasquinucci Heart Hospital - &quot;G.Monasterio&quot; Foundation</name>
      <address>
        <city>Massa</city>
        <zip>54100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CentroCardiologico Monzino</name>
      <address>
        <city>Milan</city>
        <zip>20138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica San Gaudenzio</name>
      <address>
        <city>Novara</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniversitÃ  Cattolica del Sacro Cuore Policlinico</name>
      <address>
        <city>Roma</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria &quot;Santa Maria della Misericordia&quot;</name>
      <address>
        <city>Udine</city>
        <zip>33100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut National de Chirurgie Cardiaque et Cardiologie Interventionnelle (INCCI)</name>
      <address>
        <city>Luxembourg</city>
        <zip>1210</zip>
        <country>Luxembourg</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Antonius Hospital</name>
      <address>
        <city>Nieuwegein</city>
        <zip>3430 EM / PO BOX 2500</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Arrixaca</name>
      <address>
        <city>El Palmar</city>
        <state>Murcia</state>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Complexo Hospitalario Universitario A Coruna</name>
      <address>
        <city>La Coruna</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Infirmary Hospital Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH16 4SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Thomas' Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Luxembourg</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>United Kingdom</country>
  </location_countries>
  <removed_countries>
    <country>Slovenia</country>
  </removed_countries>
  <link>
    <url>https://professional.heart.org/professional/General/UCM_423811_Classification-of-Functional-Capacity-and-Objective-Assessment.jsp</url>
    <description>New York Heart Association Classification</description>
  </link>
  <link>
    <url>https://euroqol.org/eq-5d-instruments/</url>
    <description>EuroQol Standardized Instrument (EQ-5D) developed to measure of health-related quality of life</description>
  </link>
  <link>
    <url>https://www.optum.com/solutions/life-sciences/answer-research/patient-insights/sf-health-surveys/sf-36v2-health-survey.html</url>
    <description>The Optum (SF-26v2) Health Survey questions to measure functional health and well-being from the patient's point of view</description>
  </link>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>June 29, 2016</study_first_submitted>
  <study_first_submitted_qc>September 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2016</study_first_posted>
  <results_first_submitted>July 16, 2019</results_first_submitted>
  <results_first_submitted_qc>October 18, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">November 8, 2019</results_first_posted>
  <last_update_submitted>November 12, 2019</last_update_submitted>
  <last_update_submitted_qc>November 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aortic Valve Replacement</keyword>
  <keyword>Aortic Stenosis</keyword>
  <keyword>EDWARDS INTUITY Elite</keyword>
  <keyword>Rapid deployment valves</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol, Statistical Analysis Plan, and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 12, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/63/NCT02907463/Prot_SAP_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>EDWARDS INTUITY Elite Valve System</title>
          <description>The system includes the EDWARDS INTUITY Elite Aortic Valve, Model 8300AB and the EDWARDS INTUITY Elite Delivery System, Model 8300DB.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="280"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Enrolled Cohort</title>
              <participants_list>
                <participants group_id="P1" count="280"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Per Protocol Cohort</title>
              <participants_list>
                <participants group_id="P1" count="276"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="243"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>MIS Approach was not used</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Not Implanted with Study Device</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Device Explanted</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Missing Exit Form</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Per Protocol Cohort</title>
          <description>The per protocol cohort will consist of all enrolled patients that leave the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="276"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="276"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73.7" spread="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="276"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="142"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="134"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Subject's Average Time Spent on Cardiopulmonary Cross Clamp</title>
        <description>Cardiopulmonary cross clamp time is the amount of time that the patient's aorta (blood vessel) is clamped by a surgical instrument used in cardiac surgery. This allows the normal blood flow to be sent to an artificial heart and lung machine to keep it at a constant temperature and oxygen level.</description>
        <time_frame>At time of surgery; an average of 1 hour</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Per Protocol Cohort</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Time Spent on Cardiopulmonary Cross Clamp</title>
          <description>Cardiopulmonary cross clamp time is the amount of time that the patient's aorta (blood vessel) is clamped by a surgical instrument used in cardiac surgery. This allows the normal blood flow to be sent to an artificial heart and lung machine to keep it at a constant temperature and oxygen level.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Partial Sternotomy</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="240"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.9" spread="14.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right Thoracotomy</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.2" spread="18.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="276"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.9" spread="16.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject's Average Time Spent on Cardiopulmonary Bypass.</title>
        <description>Cardiopulmonary bypass time is the amount of time that the patient's blood circulates through an artificial heart and lung machine during cardiac surgery.</description>
        <time_frame>At time of surgery; an average of 1.5 hours</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Per Protocol Cohort</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Time Spent on Cardiopulmonary Bypass.</title>
          <description>Cardiopulmonary bypass time is the amount of time that the patient's blood circulates through an artificial heart and lung machine during cardiac surgery.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.0" spread="23.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Device Technical Success Rate</title>
        <description>The successful delivery and deployment of the EDWARDS INTUITY Elite valve and delivery system, and the subject leaving the operating room with valve in place.</description>
        <time_frame>At time of surgery</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the enrolled cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Enrolled Cohort</title>
            <description>A subject was considered enrolled into the registry when he/she signed the informed consent, and met all the registry eligibility criteria.</description>
          </group>
        </group_list>
        <measure>
          <title>Device Technical Success Rate</title>
          <description>The successful delivery and deployment of the EDWARDS INTUITY Elite valve and delivery system, and the subject leaving the operating room with valve in place.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the enrolled cohort.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="280"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="276"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>First Attempt Success Rate</title>
        <description>The successful delivery and deployment of the valve and delivery system during the first attempt, and subject leaving the operating room with EDWARDS INTUITY Elite valve in place.</description>
        <time_frame>At time of surgery</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the enrolled cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Enrolled Cohort</title>
            <description>A subject was considered enrolled into the registry when he/she signed the informed consent, and met all the registry eligibility criteria.</description>
          </group>
        </group_list>
        <measure>
          <title>First Attempt Success Rate</title>
          <description>The successful delivery and deployment of the valve and delivery system during the first attempt, and subject leaving the operating room with EDWARDS INTUITY Elite valve in place.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the enrolled cohort.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="280"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="270"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedural Success</title>
        <description>Procedural success is defined as device technical success followed by the absence of adverse events requiring device reoperation, requiring implantation of permanent pacemaker (with baseline sinus rhythm and no other conduction issues), or subject death, within discharge or 10 days post index procedure whichever comes first.</description>
        <time_frame>Day of procedure and events occurring within 10 days of procedure</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the enrolled cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Enrolled Cohort</title>
            <description>A subject was considered enrolled into the registry when he/she signed the informed consent, and met all the registry eligibility criteria.</description>
          </group>
        </group_list>
        <measure>
          <title>Procedural Success</title>
          <description>Procedural success is defined as device technical success followed by the absence of adverse events requiring device reoperation, requiring implantation of permanent pacemaker (with baseline sinus rhythm and no other conduction issues), or subject death, within discharge or 10 days post index procedure whichever comes first.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the enrolled cohort.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="280"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="274"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject's Average Health Care Utilization</title>
        <description>The average amount of time the subjects spent in the intensive care unit and the average total length of hospital stay after their heart valve replacement procedure.</description>
        <time_frame>Day of surgical procedure through discharge from the hospital, an average of 3 days and 10 days respectively.</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the enrolled cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Enrolled Cohort</title>
            <description>A subject was considered enrolled into the registry when he/she signed the informed consent, and met all the registry eligibility criteria.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Health Care Utilization</title>
          <description>The average amount of time the subjects spent in the intensive care unit and the average total length of hospital stay after their heart valve replacement procedure.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the enrolled cohort.</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="278"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>ICU Length of Stay</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="277"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="7.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hospital Length of Stay</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="278"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.5" spread="6.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject's Average Mean Gradient Measurements Over Time.</title>
        <description>Mean gradient is the average flow of blood through the aortic valve measured in millimeters of mercury. Gradients are evaluated by echocardiography over time. Mean gradient values depend on the size and type of valve.</description>
        <time_frame>Baseline, Discharge and 6 months</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Per Protocol Cohort - 19mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O2">
            <title>Per Protocol Cohort - 21mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O3">
            <title>Per Protocol Cohort - 23mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O4">
            <title>Per Protocol Cohort - 25mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O5">
            <title>Per Protocol Cohort - 27mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O6">
            <title>Per Protocol Cohort - Total</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Mean Gradient Measurements Over Time.</title>
          <description>Mean gradient is the average flow of blood through the aortic valve measured in millimeters of mercury. Gradients are evaluated by echocardiography over time. Mean gradient values depend on the size and type of valve.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="89"/>
                <count group_id="O3" value="75"/>
                <count group_id="O4" value="63"/>
                <count group_id="O5" value="20"/>
                <count group_id="O6" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="68"/>
                    <count group_id="O3" value="49"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="195"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50" spread="18.1"/>
                    <measurement group_id="O2" value="46.6" spread="13.7"/>
                    <measurement group_id="O3" value="44.5" spread="13.0"/>
                    <measurement group_id="O4" value="45.3" spread="13.4"/>
                    <measurement group_id="O5" value="45.1" spread="16.5"/>
                    <measurement group_id="O6" value="46.0" spread="14.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="70"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="49"/>
                    <count group_id="O5" value="16"/>
                    <count group_id="O6" value="211"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.0" spread="5.6"/>
                    <measurement group_id="O2" value="12.8" spread="5.0"/>
                    <measurement group_id="O3" value="9.7" spread="3.4"/>
                    <measurement group_id="O4" value="9.8" spread="3.6"/>
                    <measurement group_id="O5" value="7.6" spread="3.0"/>
                    <measurement group_id="O6" value="11.1" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="65"/>
                    <count group_id="O3" value="51"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="16"/>
                    <count group_id="O6" value="199"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.7" spread="4.4"/>
                    <measurement group_id="O2" value="9.7" spread="3.4"/>
                    <measurement group_id="O3" value="8.0" spread="3.7"/>
                    <measurement group_id="O4" value="7.8" spread="2.6"/>
                    <measurement group_id="O5" value="6.1" spread="2.9"/>
                    <measurement group_id="O6" value="8.8" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject's Average Peak Gradients Measurements Over Time.</title>
        <description>Peak gradient is the maximum value measured of flow of blood through the aortic valve as measured in millimeters of mercury. Gradients are evaluated by echocardiography over time.</description>
        <time_frame>Baseline, Discharge and 6 months</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Per Protocol Cohort - 19mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O2">
            <title>Per Protocol Cohort - 21mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O3">
            <title>Per Protocol Cohort - 23mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O4">
            <title>Per Protocol Cohort - 25mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O5">
            <title>Per Protocol Cohort - 27mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O6">
            <title>Per Protocol Cohort - Total</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Peak Gradients Measurements Over Time.</title>
          <description>Peak gradient is the maximum value measured of flow of blood through the aortic valve as measured in millimeters of mercury. Gradients are evaluated by echocardiography over time.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="89"/>
                <count group_id="O3" value="75"/>
                <count group_id="O4" value="63"/>
                <count group_id="O5" value="20"/>
                <count group_id="O6" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="68"/>
                    <count group_id="O3" value="49"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="195"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.3" spread="25.9"/>
                    <measurement group_id="O2" value="78.9" spread="22.8"/>
                    <measurement group_id="O3" value="73.4" spread="20.8"/>
                    <measurement group_id="O4" value="74.8" spread="20.9"/>
                    <measurement group_id="O5" value="74.0" spread="22.0"/>
                    <measurement group_id="O6" value="76.3" spread="22.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="70"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="49"/>
                    <count group_id="O5" value="16"/>
                    <count group_id="O6" value="211"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.0" spread="10.4"/>
                    <measurement group_id="O2" value="25.0" spread="10.7"/>
                    <measurement group_id="O3" value="18.4" spread="6.6"/>
                    <measurement group_id="O4" value="18.6" spread="7.3"/>
                    <measurement group_id="O5" value="15.3" spread="6.2"/>
                    <measurement group_id="O6" value="21.4" spread="9.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="65"/>
                    <count group_id="O3" value="51"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="16"/>
                    <count group_id="O6" value="199"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.6" spread="8.4"/>
                    <measurement group_id="O2" value="19.7" spread="7.6"/>
                    <measurement group_id="O3" value="15.7" spread="6.7"/>
                    <measurement group_id="O4" value="15.0" spread="4.7"/>
                    <measurement group_id="O5" value="12.6" spread="4.9"/>
                    <measurement group_id="O6" value="17.5" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject's Average Effective Orifice Area (EOA) Measurements Over Time</title>
        <description>Effective orifice area represents the cross-sectional area of the blood flow downstream of the aortic valve. Effective orifice area is evaluated by echocardiography over time.</description>
        <time_frame>Baseline, Discharge and 6 months</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Per Protocol Cohort - 19mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O2">
            <title>Per Protocol Cohort - 21mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O3">
            <title>Per Protocol Cohort - 23mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O4">
            <title>Per Protocol Cohort - 25mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O5">
            <title>Per Protocol Cohort - 27mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O6">
            <title>Per Protocol Cohort - Total</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Effective Orifice Area (EOA) Measurements Over Time</title>
          <description>Effective orifice area represents the cross-sectional area of the blood flow downstream of the aortic valve. Effective orifice area is evaluated by echocardiography over time.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
          <units>centimeters squared</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="89"/>
                <count group_id="O3" value="75"/>
                <count group_id="O4" value="63"/>
                <count group_id="O5" value="20"/>
                <count group_id="O6" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="61"/>
                    <count group_id="O3" value="47"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="177"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="0.2"/>
                    <measurement group_id="O2" value="0.8" spread="0.3"/>
                    <measurement group_id="O3" value="0.8" spread="0.2"/>
                    <measurement group_id="O4" value="0.9" spread="0.2"/>
                    <measurement group_id="O5" value="1.0" spread="0.2"/>
                    <measurement group_id="O6" value="0.8" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="54"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="14"/>
                    <count group_id="O6" value="172"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="0.3"/>
                    <measurement group_id="O2" value="1.5" spread="0.6"/>
                    <measurement group_id="O3" value="1.9" spread="0.6"/>
                    <measurement group_id="O4" value="2.0" spread="0.6"/>
                    <measurement group_id="O5" value="2.3" spread="0.7"/>
                    <measurement group_id="O6" value="1.8" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="58"/>
                    <count group_id="O3" value="48"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="16"/>
                    <count group_id="O6" value="184"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="0.3"/>
                    <measurement group_id="O2" value="1.5" spread="0.4"/>
                    <measurement group_id="O3" value="1.9" spread="0.5"/>
                    <measurement group_id="O4" value="2.1" spread="0.5"/>
                    <measurement group_id="O5" value="2.5" spread="0.6"/>
                    <measurement group_id="O6" value="1.8" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject's Average Effective Orifice Area Index (EOAI) Measurement Over Time.</title>
        <description>Effective orifice area index represents the minimal cross-sectional area of the blood flow downstream of the aortic valve divided by the person's body surface area. Effective orifice area index is evaluated by echocardiography over time.</description>
        <time_frame>Discharge and 6 months</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Per Protocol Cohort - 19mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O2">
            <title>Per Protocol Cohort - 21mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O3">
            <title>Per Protocol Cohort - 23mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O4">
            <title>Per Protocol Cohort - 25mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O5">
            <title>Per Protocol Cohort - 27mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O6">
            <title>Per Protocol Cohort - Total</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Effective Orifice Area Index (EOAI) Measurement Over Time.</title>
          <description>Effective orifice area index represents the minimal cross-sectional area of the blood flow downstream of the aortic valve divided by the person's body surface area. Effective orifice area index is evaluated by echocardiography over time.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
          <units>centimeters squared/meters squared</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="89"/>
                <count group_id="O3" value="75"/>
                <count group_id="O4" value="63"/>
                <count group_id="O5" value="20"/>
                <count group_id="O6" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="36"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="14"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="0.2"/>
                    <measurement group_id="O2" value="0.9" spread="0.4"/>
                    <measurement group_id="O3" value="1.0" spread="0.3"/>
                    <measurement group_id="O4" value="1.0" spread="0.3"/>
                    <measurement group_id="O5" value="1.1" spread="0.4"/>
                    <measurement group_id="O6" value="0.9" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="45"/>
                    <count group_id="O3" value="34"/>
                    <count group_id="O4" value="30"/>
                    <count group_id="O5" value="13"/>
                    <count group_id="O6" value="139"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="0.1"/>
                    <measurement group_id="O2" value="0.8" spread="0.2"/>
                    <measurement group_id="O3" value="1.0" spread="0.3"/>
                    <measurement group_id="O4" value="1.1" spread="0.3"/>
                    <measurement group_id="O5" value="1.2" spread="0.3"/>
                    <measurement group_id="O6" value="0.9" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject's Average Performance Index Measurements Over Time.</title>
        <description>Performance index is defined as the subject's effective orifice area (the cross-sectional area of the blood flow downstream of the aortic valve) divided by the subject's pre-implant orifice area. Effective orifice area is evaluated by echocardiography over time.</description>
        <time_frame>Baseline, Discharge and 6 months</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Per Protocol Cohort - 19mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O2">
            <title>Per Protocol Cohort - 21mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O3">
            <title>Per Protocol Cohort - 23mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O4">
            <title>Per Protocol Cohort - 25mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O5">
            <title>Per Protocol Cohort - 27mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O6">
            <title>Per Protocol Cohort - Total</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Performance Index Measurements Over Time.</title>
          <description>Performance index is defined as the subject's effective orifice area (the cross-sectional area of the blood flow downstream of the aortic valve) divided by the subject's pre-implant orifice area. Effective orifice area is evaluated by echocardiography over time.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
          <units>cm2/cm2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="89"/>
                <count group_id="O3" value="75"/>
                <count group_id="O4" value="63"/>
                <count group_id="O5" value="20"/>
                <count group_id="O6" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="61"/>
                    <count group_id="O3" value="47"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="177"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="0.1"/>
                    <measurement group_id="O2" value="0.5" spread="0.2"/>
                    <measurement group_id="O3" value="0.4" spread="0.1"/>
                    <measurement group_id="O4" value="0.4" spread="0.1"/>
                    <measurement group_id="O5" value="0.4" spread="0.1"/>
                    <measurement group_id="O6" value="0.5" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="54"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="14"/>
                    <count group_id="O6" value="172"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="0.2"/>
                    <measurement group_id="O2" value="1.0" spread="0.4"/>
                    <measurement group_id="O3" value="1.0" spread="0.3"/>
                    <measurement group_id="O4" value="1.0" spread="0.3"/>
                    <measurement group_id="O5" value="0.9" spread="0.3"/>
                    <measurement group_id="O6" value="1.0" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="58"/>
                    <count group_id="O3" value="48"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="16"/>
                    <count group_id="O6" value="184"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="0.2"/>
                    <measurement group_id="O2" value="1.0" spread="0.2"/>
                    <measurement group_id="O3" value="1.0" spread="0.3"/>
                    <measurement group_id="O4" value="1.0" spread="0.2"/>
                    <measurement group_id="O5" value="1.0" spread="0.2"/>
                    <measurement group_id="O6" value="1.0" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject's Average Cardiac Output Over Time</title>
        <description>The amount of blood the heart pumps through the circulatory system in a minute.</description>
        <time_frame>Baseline, Discharge and 6 months</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Per Protocol Cohort - 19mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O2">
            <title>Per Protocol Cohort - 21mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O3">
            <title>Per Protocol Cohort - 23mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O4">
            <title>Per Protocol Cohort - 25mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O5">
            <title>Per Protocol Cohort - 27mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O6">
            <title>Per Protocol Cohort - Total</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Cardiac Output Over Time</title>
          <description>The amount of blood the heart pumps through the circulatory system in a minute.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
          <units>liters per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="89"/>
                <count group_id="O3" value="75"/>
                <count group_id="O4" value="63"/>
                <count group_id="O5" value="20"/>
                <count group_id="O6" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="61"/>
                    <count group_id="O3" value="45"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="173"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8" spread="1.2"/>
                    <measurement group_id="O2" value="5.3" spread="1.5"/>
                    <measurement group_id="O3" value="5.4" spread="1.3"/>
                    <measurement group_id="O4" value="6.1" spread="1.8"/>
                    <measurement group_id="O5" value="6.2" spread="1.5"/>
                    <measurement group_id="O6" value="5.5" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="53"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="13"/>
                    <count group_id="O6" value="169"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="1.1"/>
                    <measurement group_id="O2" value="4.9" spread="1.7"/>
                    <measurement group_id="O3" value="5.4" spread="1.5"/>
                    <measurement group_id="O4" value="5.7" spread="1.6"/>
                    <measurement group_id="O5" value="5.0" spread="1.4"/>
                    <measurement group_id="O6" value="5.1" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="59"/>
                    <count group_id="O3" value="48"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="184"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="0.9"/>
                    <measurement group_id="O2" value="4.5" spread="1.0"/>
                    <measurement group_id="O3" value="4.8" spread="1.4"/>
                    <measurement group_id="O4" value="5.2" spread="1.0"/>
                    <measurement group_id="O5" value="5.4" spread="1.6"/>
                    <measurement group_id="O6" value="4.8" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject's Average Cardiac Index</title>
        <description>A measure of cardiac output per square meter of body surface area</description>
        <time_frame>Discharge and 6 months</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Per Protocol Cohort - 19mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O2">
            <title>Per Protocol Cohort - 21mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O3">
            <title>Per Protocol Cohort - 23mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O4">
            <title>Per Protocol Cohort - 25mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O5">
            <title>Per Protocol Cohort - 27mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O6">
            <title>Per Protocol Cohort - Total</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Cardiac Index</title>
          <description>A measure of cardiac output per square meter of body surface area</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
          <units>L/min/meters squared</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="89"/>
                <count group_id="O3" value="75"/>
                <count group_id="O4" value="63"/>
                <count group_id="O5" value="20"/>
                <count group_id="O6" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="36"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="13"/>
                    <count group_id="O6" value="148"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="0.6"/>
                    <measurement group_id="O2" value="2.7" spread="0.8"/>
                    <measurement group_id="O3" value="2.8" spread="0.8"/>
                    <measurement group_id="O4" value="2.8" spread="0.8"/>
                    <measurement group_id="O5" value="2.4" spread="0.7"/>
                    <measurement group_id="O6" value="2.7" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="45"/>
                    <count group_id="O3" value="34"/>
                    <count group_id="O4" value="30"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="138"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="0.3"/>
                    <measurement group_id="O2" value="2.5" spread="0.6"/>
                    <measurement group_id="O3" value="2.6" spread="0.9"/>
                    <measurement group_id="O4" value="2.6" spread="0.5"/>
                    <measurement group_id="O5" value="2.6" spread="0.6"/>
                    <measurement group_id="O6" value="2.6" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject's Amount of Paravalvular Leak Over Time.</title>
        <description>Paravalvular leak refers to blood flowing through a channel between the implanted artificial valve and the cardiac tissue as a result of inappropriate sealing. Paravalvular leak is evaluated by echocardiography over time. It is assessed on a scale from minimum of 0 to maximum of 4, where 0 = no leak, 1 = a trace leak, 2 = a mild leak, 3 = a moderate leak, and 4 = a severe leak. Higher numbers on the scale show a worsening outcome.</description>
        <time_frame>Discharge and 6 months</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Per Protocol Cohort - 19mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O2">
            <title>Per Protocol Cohort - 21mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O3">
            <title>Per Protocol Cohort - 23mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O4">
            <title>Per Protocol Cohort - 25mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O5">
            <title>Per Protocol Cohort - 27mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O6">
            <title>Per Protocol Cohort - All Subjects</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Amount of Paravalvular Leak Over Time.</title>
          <description>Paravalvular leak refers to blood flowing through a channel between the implanted artificial valve and the cardiac tissue as a result of inappropriate sealing. Paravalvular leak is evaluated by echocardiography over time. It is assessed on a scale from minimum of 0 to maximum of 4, where 0 = no leak, 1 = a trace leak, 2 = a mild leak, 3 = a moderate leak, and 4 = a severe leak. Higher numbers on the scale show a worsening outcome.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="89"/>
                <count group_id="O3" value="75"/>
                <count group_id="O4" value="63"/>
                <count group_id="O5" value="20"/>
                <count group_id="O6" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="68"/>
                    <count group_id="O3" value="50"/>
                    <count group_id="O4" value="51"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="204"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>0 None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="59"/>
                    <measurement group_id="O3" value="45"/>
                    <measurement group_id="O4" value="45"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="182"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+1 Trivial/Trace</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+2 Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+3 Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+4 Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="62"/>
                    <count group_id="O3" value="53"/>
                    <count group_id="O4" value="45"/>
                    <count group_id="O5" value="16"/>
                    <count group_id="O6" value="196"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>0 None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="55"/>
                    <measurement group_id="O3" value="49"/>
                    <measurement group_id="O4" value="40"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="177"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+1 Trivial/Trace</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+2 Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+3 Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+4 Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject's Amount of Aortic Valvular Regurgitation Over Time.</title>
        <description>Aortic valvular regurgitation occurs when the aortic valve in the heart does not close tightly allowing some of the blood that was pumped out of the heart to leak back into it. Aortic valvular regurgitation is evaluated by echocardiography over time. It is assessed on a scale from minimum of 0 to maximum of 4, where 0 = no leak, 1 = a trace leak, 2 = a mild leak, 3 = a moderate leak, and 4 = a severe leak. Higher numbers on the scale show a worsening outcome.</description>
        <time_frame>Discharge and 6 Months</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Per Protocol Cohort - 19mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O2">
            <title>Per Protocol Cohort - 21mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O3">
            <title>Per Protocol Cohort - 23mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O4">
            <title>Per Protocol Cohort - 25mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O5">
            <title>Per Protocol Cohort - 27mm</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
          <group group_id="O6">
            <title>Per Protocol Cohort - Total</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Amount of Aortic Valvular Regurgitation Over Time.</title>
          <description>Aortic valvular regurgitation occurs when the aortic valve in the heart does not close tightly allowing some of the blood that was pumped out of the heart to leak back into it. Aortic valvular regurgitation is evaluated by echocardiography over time. It is assessed on a scale from minimum of 0 to maximum of 4, where 0 = no leak, 1 = a trace leak, 2 = a mild leak, 3 = a moderate leak, and 4 = a severe leak. Higher numbers on the scale show a worsening outcome.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="89"/>
                <count group_id="O3" value="75"/>
                <count group_id="O4" value="63"/>
                <count group_id="O5" value="20"/>
                <count group_id="O6" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="68"/>
                    <count group_id="O3" value="51"/>
                    <count group_id="O4" value="51"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="205"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>0 None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="61"/>
                    <measurement group_id="O3" value="48"/>
                    <measurement group_id="O4" value="40"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="178"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+1 Trivial/Trace</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+2 Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+3 Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+4 Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="62"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="45"/>
                    <count group_id="O5" value="16"/>
                    <count group_id="O6" value="197"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>0 None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="54"/>
                    <measurement group_id="O3" value="46"/>
                    <measurement group_id="O4" value="40"/>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="167"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+1 Trivial/Trace</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+2 Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+3 Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+4 Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Average SF-36 Physical Health Summary</title>
        <description>The Medical Outcomes Study Short-Form 36 - Physical Health Summary The SF-36 questionnaire scale ranges from 100, which reflects the best health status to 0, which reflects the worse health status.</description>
        <time_frame>Baseline and 6 months</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Per Protocol Cohort</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average SF-36 Physical Health Summary</title>
          <description>The Medical Outcomes Study Short-Form 36 - Physical Health Summary The SF-36 questionnaire scale ranges from 100, which reflects the best health status to 0, which reflects the worse health status.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="209"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.6" spread="8.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="209"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.6" spread="8.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Average SF-36 Mental Health Summary</title>
        <description>The Medical Outcomes Study Short-Form 36 - Mental Health Summary The SF-36 questionnaire scale ranges from 100, which reflects the best health status to 0, which reflects the worse health status.</description>
        <time_frame>Baseline and 6 months</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Per Protocol Cohort</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average SF-36 Mental Health Summary</title>
          <description>The Medical Outcomes Study Short-Form 36 - Mental Health Summary The SF-36 questionnaire scale ranges from 100, which reflects the best health status to 0, which reflects the worse health status.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="209"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.5" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="209"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.1" spread="10.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's New York Heart Association (NYHA) Functional Class Compared to Baseline</title>
        <description>The New York Heart Association (NYHA) functional classification system relates symptoms to everyday activities and the patient's quality of life. Class I. Patients with cardiac disease but without resulting limitation of physical activity.
Class II. Patients with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest.
Class III. Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest.
Class IV. Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort.
Symptoms of heart failure or the anginal syndrome may be present even at rest.</description>
        <time_frame>6 months compared to baseline</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Per Protocol Cohort</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's New York Heart Association (NYHA) Functional Class Compared to Baseline</title>
          <description>The New York Heart Association (NYHA) functional classification system relates symptoms to everyday activities and the patient's quality of life. Class I. Patients with cardiac disease but without resulting limitation of physical activity.
Class II. Patients with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest.
Class III. Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest.
Class IV. Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort.
Symptoms of heart failure or the anginal syndrome may be present even at rest.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="239"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Preoperative Classification, Class I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Class I</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Class II</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Class III</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Class IV</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Preoperative Classification, Class II</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="111"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Class I</title>
                  <measurement_list>
                    <measurement group_id="O1" value="85"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Class II</title>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Class III</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Class IV</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Preoperative Classification, Class III</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="115"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Class I</title>
                  <measurement_list>
                    <measurement group_id="O1" value="71"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Class II</title>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Class III</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Class IV</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Preoperative Classification, Class IV</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Class I</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Class II</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Class III</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Class IV</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All Subjects</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="239"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Class I</title>
                  <measurement_list>
                    <measurement group_id="O1" value="169"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Class II</title>
                  <measurement_list>
                    <measurement group_id="O1" value="63"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Class III</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Class IV</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Average Score on the EQ-5D - Quality of Life Questionnaire Over Time</title>
        <description>The EuroQol-5 Dimension (EQ-5D) is a standardized questionnaire that asks subjects to rate themselves (no problems, some problems, extreme problems) on mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The scale is indexed and ranges from a minimum of 0.275 and a maximum of 1.000. A lower number indicates the participants experiences more problems and a higher number indicates the participants experiences fewer problems.</description>
        <time_frame>Baseline and 6 months</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Per Protocol Cohort</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Score on the EQ-5D - Quality of Life Questionnaire Over Time</title>
          <description>The EuroQol-5 Dimension (EQ-5D) is a standardized questionnaire that asks subjects to rate themselves (no problems, some problems, extreme problems) on mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The scale is indexed and ranges from a minimum of 0.275 and a maximum of 1.000. A lower number indicates the participants experiences more problems and a higher number indicates the participants experiences fewer problems.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="211"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.73" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="211"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.82" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Average Fitness for Hospital Discharge</title>
        <description>Considered as the day at which the patient was fit for hospital discharge.</description>
        <time_frame>Day of surgical procedure through discharge from the hospital; an average of 7 days</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Per Protocol Cohort</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Fitness for Hospital Discharge</title>
          <description>Considered as the day at which the patient was fit for hospital discharge.</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="275"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.8" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Early Adverse Events Divided by Number of Subjects (Expressed as a Percentage)</title>
        <description>Number of early adverse events occurring within 30 days of procedure divided by the number of enrolled subjects times 100</description>
        <time_frame>Events occurring within 30 days of procedure</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Per Protocol Cohort</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Early Adverse Events Divided by Number of Subjects (Expressed as a Percentage)</title>
          <description>Number of early adverse events occurring within 30 days of procedure divided by the number of enrolled subjects times 100</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
          <units>Percentage of events/subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>All Cause Mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Trial Valve Related Mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thromboembolism</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TIA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-cerebral Embolism</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Valve Thrombosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Major Bleeding</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minor Paravalvular Leak (OPC)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Major Paravalvular Leak (OPC)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hemolysis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NSVD Other than PVL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Endocarditis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Structural Valve Deterioration</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Reoperation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Explant</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Renal Failure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Respiratory Failure/Dysfunction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Deep Sternal Wound Infection</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Permanent Pacemaker Implant</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Late Adverse Events Divided by Late Patient Years (Expressed as a Percentage)</title>
        <description>Number of late adverse events divided by the total number of late patient years x 100. Late patient years are calculated from 31 days post-implant to the date of the last contact (follow up or adverse event).</description>
        <time_frame>Events occuring &gt;= 31 days and up through 6 months</time_frame>
        <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Per Protocol Cohort</title>
            <description>The per protocol cohort consists of all enrolled patients that left the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Late Adverse Events Divided by Late Patient Years (Expressed as a Percentage)</title>
          <description>Number of late adverse events divided by the total number of late patient years x 100. Late patient years are calculated from 31 days post-implant to the date of the last contact (follow up or adverse event).</description>
          <population>The outcome is reported for subjects where data is available. Analysis is based on the per protocol cohort.</population>
          <units>percentage of events/late patient years</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>All Cause Mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Trial Valve Related Mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thromboembolism</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TIA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-cerebral Embolism</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Valve Thrombosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Major Bleeding</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minor Paravalvular Leak (OPC)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Major Paravalvular Leak (OPC)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hemolysis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NSVD Other than PVL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Endocarditis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Structural Valve Deterioration</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Reoperation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Explant</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Renal Failure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Respiratory Failure/Dysfunction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Deep Sternal Wound Infection</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Permanent Pacemaker Implant</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Events occurring from baseline through 6 months post implant</time_frame>
      <desc>This outcome is reported for subjects who received an EDWARDS INTUITY Elite Valve System where data is available.</desc>
      <group_list>
        <group group_id="E1">
          <title>Per Protocol Cohort</title>
          <description>The per protocol cohort will consist of all enrolled patients that leave the operating room with the registry valve in place and had an AVR MIS surgery procedure.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="108" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia - Bleeding related - Minor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Bleeding - Cardiovascular - Major</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Bleeding - Gastrointestinal Lower - Minor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Bleeding - Gastrointestinal Upper - Major</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Bleeding - Gastrointestinal Upper - Minor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Bleeding - Neurological - Major</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Splenic complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Arrhythmia - AV Block - 1st degree</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - AV Block - 2nd degree</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - AV Block - 3rd degree</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Atrial Flutter</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Bundle Branch Block - Left</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Paroxysmal Atrial Fibrillation (PAF)</sub_title>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Permanent Atrial Fibrillation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Persistent Atrial Fibrillation</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Supraventricular Tachycardia (SVT)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Tachy-Bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Ventricular Fibrillation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Cardiac Arrest</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Chordae tendineae damage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Heart Failure - Acute</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Heart Failure - Chronic (CHF)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>NSVD - LVOT damage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>NSVD - Paravalvular Leak - +2</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Perforation - Atrial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion - Major</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion - Minor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Pericardial Tamponade</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Pleural Effusion - Bilateral</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Pleural Effusion - Left</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Pleural Effusion - Right</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Thromboembolic Event - Other - Central - Hemiparesis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Thromboembolic Event - Stroke</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Hearing disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Biliary (Gallbladder)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Gastrointestinal - Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Gastrointestinal - Other</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Pancreatic complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Cancer - Newly diagnosed</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Cancer - Progression of underlying disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Fever - Unknown Origin</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Multi-System organ failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Nonspecific, Unknown, or Other Body System - Other complication</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Sudden, Unexplained Death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Deep Sternal Wound / Thoracic Infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Infection / Inflammation - Other</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Superficial Wound Infection - Sternal</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Bone Fracture / Break</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Muscular Skeletal / Dermatologic - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Psychiatric - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Psychiatric Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Transient Psychotic Syndrome</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal Dysfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Renal Failure - Acute</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Renal â€“ Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection (UTI)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism - Right</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Respiratory Failure - COPD</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Respiratory Failure - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Respiratory Failure - Pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Respiratory Infection - Lower (Bronchitis)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Respiratory Infection - Pneumonia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Respiratory Insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Vascular - Access Site Complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Vascular - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="155" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia - Bleeding related - Minor</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Anemia - Non-bleeding related</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Bleeding - Cardiovascular - Major</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Bleeding - Genitourinary - Major</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Bleeding - Genitourinary - Minor</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Bleeding - Musculoskeletal/Dermatological - Minor</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Bleeding - Pulmonary/Respiratory Minor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Blood/ Lymphatic - Other</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia - Heparin Induced (HIT)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina, Stable</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - AV Block - 1st degree</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - AV Block - 2nd degree</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - AV Block - 3rd degree</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Atrial Flutter</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Bradycardia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Bundle Branch Block - Left</sub_title>
                <counts group_id="E1" events="53" subjects_affected="53" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Bundle Branch Block - Right</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Paroxysmal Atrial Fibrillation (PAF)</sub_title>
                <counts group_id="E1" events="59" subjects_affected="57" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Paroxysmal Atrial Tachycardia (PAT)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Persistent Atrial Fibrillation</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Tachy-Bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Tachycardia - Non-Ventricular</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Tachycardia - Ventricular</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Ventricular Fibrillation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Cardiogenic Shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Cardiovascular - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Hypertension - Pulmonary</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Hypertension - Systemic</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>NSVD - Paravalvular Leak - +1</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>NSVD - Paravalvular Leak - +2</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion - Minor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Pleural Effusion - Bilateral</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Pleural Effusion - Left</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Pleural Effusion - Right</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Regurgitation - Aortic-Central/Transvalvular-+1</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Endocrine complications</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal - Other</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fever - Unknown Origin</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Nonspecific, Unknown, or Other Body System - Other complication</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatic complication - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal - Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Infection / Inflammation - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Respiratory Infection - Lower (Bronchitis)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Respiratory Infection - Pneumonia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Superficial Wound Infection - Sternal</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Wound Infection - Other</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Metabolic complications</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Bone Fracture / Break</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Muscular Skeletal / Dermatologic - Other</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Psychiatric - Other</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Psychiatric Disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Transient Psychotic Syndrome</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal Dysfunction</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Renal Failure - Acute</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection (UTI)</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Pulmonary/Respiratory - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Respiratory Insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Vascular - Access Site Complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
              <event>
                <sub_title>Vascular - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="280"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>PI can't publish/present on overall study results not yet published but may publish his own data subject to EW review prior to submission/presentation, but data analyses of site-specific results can occur only in intervals as specified in the CTA. Publication/presentation of the PIâ€™s site-specific results of devices which haven't been market released and which still may be undergoing development, shall not include claims of device safety/effectiveness and will require the review/approval of EW.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Mary Edwards, VP Clinical and Regulatory Affairs, Surgical Structural Heart</name_or_title>
      <organization>Edwards Lifesciences, LLC</organization>
      <phone>949-250-2500 ext 1536</phone>
      <email>mary_edwards@edwards.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

